Stock AUROPHARMA AUROBINDO PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Aurobindo Pharma

Equities

AUROPHARMA

INE406A01037

Delayed NSE India S.E.
Other stock markets
 05:33:13 2024-06-13 am EDT 		5-day change 1st Jan Change
1,254 INR +0.42% Intraday chart for Aurobindo Pharma +0.17% +15.63%
Jun. 05 Hindalco-owned Novelis delays US IPO; shares slide RE
May. 27 Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President ­ R&D (Specialty Drug Delivery)
CI
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024
CI
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer
CI
Aurobindo Pharma Limited Approves the Resignation of Dr.(Mrs.) Avnit Bimal Singh as an Independent Director
CI
Aurobindo Pharma Chief Operating Officer (Formulations) Passes Away
MT
Aurobindo Pharma Limited Announces Resignation of M. Sivakumaran as Whole-Time Director and Director
CI
Aurobindo Pharma Unit Names New CEO
MT
Aurobindo Pharma Limited Announces Appointment of Venkat Nageswar Chalasani as Independent Director of Apitoria Pharma Pvt. Ltd
CI
Aurobindo Pharma Limited Announces Appointment of Sanjay Chaturvedi as Chief Executive Officer
CI
Aurobindo Pharma Appoints New Managing Director
MT
Aurobindo Pharma Limited Announces Executive Changes
CI
Aurobindo Pharma Limited Announces Board Changes
CI
Aurobindo Pharma : Managing Director Resigns
MT
Aurobindo Pharma Limited Announces Management Changes
CI
Aurobindo Pharma Limited Announces Retirement of M. Sitarama Murty as an Independent Director
CI
Aurobindo Pharma Limited Announces Change in Directorate
CI
Aurobindo Pharma Limited Announces Board Changes
CI
Aurobindo Pharma Ltd Announces Executive Changes
CI
Aurobindo Pharma Ltd Appoints P. Sarath Chandra Reddy as Wholetime Director, Effective from June 01, 2016
CI
Sanjeev Dani Joins Aurobindo Pharma as COO
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AUROPHARMA Stock
  4. News Aurobindo Pharma
  5. Insiders